Celares GmbH
Home  |  Contact  |  Imprint
celares GmbH celares GmbH celares GmbH celares GmbH celares GmbH
 
 
 

News release

News release

Merck Millipore and celares GmbH
announce collaboration

New: Discrete 4-arm-PEG Maleimide

New: Discrete 4-arm-PEG Maleimide

The multimerisation with discrete 4-arm PEG facilitates defined linker lenght according to binding requirments

Hydrophilic linkers for ADCs

Hydrophilic linkers for ADCs

celares PEG based linker increase solubility of hydrophobic cytotoxic drugs

Brochures & Flyers

Celares - From Development to Production

Celares - From Development to Production

celares GmbH has outstanding technical know-how in the fields of synthetix chemistry, biotechnology and bioanalytics wich is complemented by a high level of experitse and many years of experience in the areas of polymer materials, modified protein drugs and PEGylation.

PEGylation feasibility studies at celares GmbH

PEGylation feasibility studies at celares GmbH

PEGylation is an established method for the delivery of biopharmaceuticals. The modification with polyethylene glycol (PEG) is capable of improving the pharmacological and physico-chemical properties of a drug significantly. Thus, PEGylation today is mandatory to think about when developing a biopharmaceutical drug.

Celares - scil proteins

Celares - scil proteins

Celares GmbH and Scil Proteins GmbH offer a one-stop-solution for supply and manufacturing of PEGylated Proteins

Customized PEGylation of Biopharmaceuticals

Customized PEGylation of Biopharmaceuticals

PEGylation is an established tool to increase potency, half-life and solubility of biopharmaceuticals. celares GmbH offers customized PEGylation services for the development of PEGylated drugs.

cGMP PEG for the PEGylation of peptides and proteins

cGMP PEG for the PEGylation of peptides and proteins

At its location in Berlin-Buch, Germany, celares GmbH manufactures activated polyethylene glycol (PEG) according to cGMP for the use in PEGylation, an established tool to increase potency, half-life and solubility of biopharmaceuticals. Activated PEGs are key starting materials for the manufacturing of PEGylated drugs.

CelaSYS – Customized PEGylation Solutions BOS CMC Copenhagen 2012

CelaSYS – Customized PEGylation Solutions BOS CMC Copenhagen 2012

Celares - CUSTOMIZED PEGYLATION SOLUTIONS

Celares - CUSTOMIZED PEGYLATION SOLUTIONS